Company overview
Founded in June 2024, MicroDoctor Biomedical Inc. is a newly established company backed by DARWIN Precision Co., Ltd., specializing in microneedle patch technology and microfluidic chips. Microneedle technology has been successfully applied in the mass production of products for medical aesthetics and skincare, with plans to expand into pharmaceutical and vaccine patch applications. Microfluidic chip systems are a suitable solution for organ-on-a-chip models, biosensing chips, and relevant integrated platforms. We aim to drive progress in future medical advancements.
Our production facility in Taiwan holds multiple patents and international quality certifications, including ISO 22716 Cosmetics — Good Manufacturing Practices (GMP) certification. We are also on track to obtain QMS and ISO 13485 medical device manufacturing certifications by the second half of 2025.
We operate world-class cleanrooms, utilize state-of-the-art production equipment, and are supported by a highly skilled technical team. Committed to passion, quality, and innovation, we specialize in the design, research, development, and manufacturing of medical aesthetics products and microfluidic biochip products. Furthermore, we provide customized, one-on-one professional services for the entire process, from product development to production and mass manufacturing. We can provide optimal solutions and recommendations to meet your needs from production to delivery.
Our production facility in Taiwan holds multiple patents and international quality certifications, including ISO 22716 Cosmetics — Good Manufacturing Practices (GMP) certification. We are also on track to obtain QMS and ISO 13485 medical device manufacturing certifications by the second half of 2025.
We operate world-class cleanrooms, utilize state-of-the-art production equipment, and are supported by a highly skilled technical team. Committed to passion, quality, and innovation, we specialize in the design, research, development, and manufacturing of medical aesthetics products and microfluidic biochip products. Furthermore, we provide customized, one-on-one professional services for the entire process, from product development to production and mass manufacturing. We can provide optimal solutions and recommendations to meet your needs from production to delivery.
Our mission
Our mission is to apply innovative technologies to redefine the future goals of human health, beauty, and the development of the medical industry.
Through advanced microneedle technology, we are committed not only to the field of beauty but also to the development of efficient and safe drug delivery systems and innovative vaccination solutions. By harnessing the potential of microneedle technology, our aim is to enhance therapeutic efficacy, reduce patient discomfort, and promote public health. Our goal is to become a global leader in microneedle technology, driving the future of medical and beauty care, and ensuring that everyone has access to convenient and effective treatment.
We have also extended the use of optical microstructure processing and manufacturing technologies to provide comprehensive and advanced biosensor system solutions. This accelerates market adoption and brings benefits to more people around the world. We envision a future where new drug development no longer relies on animal testing, reducing the sacrifice of life and advancing the development of new drugs toward faster, personalized precision medicine. We strive to contribute to human health and medical advancement, aligning with the SDG goal of “ensuring healthy lives and promoting well-being for all at all ages.”
Let us work together to create a healthier and more sustainable quality of life for the world of tomorrow.
Through advanced microneedle technology, we are committed not only to the field of beauty but also to the development of efficient and safe drug delivery systems and innovative vaccination solutions. By harnessing the potential of microneedle technology, our aim is to enhance therapeutic efficacy, reduce patient discomfort, and promote public health. Our goal is to become a global leader in microneedle technology, driving the future of medical and beauty care, and ensuring that everyone has access to convenient and effective treatment.
We have also extended the use of optical microstructure processing and manufacturing technologies to provide comprehensive and advanced biosensor system solutions. This accelerates market adoption and brings benefits to more people around the world. We envision a future where new drug development no longer relies on animal testing, reducing the sacrifice of life and advancing the development of new drugs toward faster, personalized precision medicine. We strive to contribute to human health and medical advancement, aligning with the SDG goal of “ensuring healthy lives and promoting well-being for all at all ages.”
Let us work together to create a healthier and more sustainable quality of life for the world of tomorrow.
Core technology
Precision Machining &
Mold Manufacturing
Mold Manufacturing
Automated Production Processes
Patented Formulation
Precision machining technology
Optical-mechanical-electrical integration and material development technology
Mold design, production and injection equipment
Our team
Our R&D team is continuously innovating, developing new materials and technologies based on our core expertise. To date, we have secured three patents related to facial masks and twelve patents for microneedle technology. Our microneedle patent strategy covers formulations, microstructure processing, design, packaging, and various applications.
Previous
Next
RD Center
A professional team with passion, quality and innovation can meet customer needs and provide the best solutions and suggestions.
The Factory
More than 2,000 square meters of cleanroom for production, and gradually introduced ISO, GMP, QMS standards.
